Abstract
The molecular scaffold, 14-3-3?, was previously found to be essential for visceral adipogenesis, but its contributions to the function of mature adipocytes is not known. As it can regulate the activities of metabolic effectors, we hypothesized that 14-3-3? also has essential roles in adipocyte function. 3T3-L1 adipocytes and mouse models were used to study if 14-3-3? regulates lipolysis. Depletion of 14-3-3? by siRNA abrogated glycerol and free fatty acid (FFA) release from 3T3-L1 cells treated with Isoproterenol (ISO, 1 μM), Forskolin (FSK, 10 μM), and dibutyryl cAMP (1 mM). In contrast, over-expression of 14-3-3? potentiated ISO-mediated FFA release. Knockdown of 14-3-3? did not affect cAMP generation in ISO- and FSK-treated 3T3-L1 cells, but mRNA levels of lipases (Atgl, Hsl, and Magl) and Pparg were reduced, suggesting a loss of adipocyte identity. Decreased activation and total expression of PKA substrates, including Hsl and CREB, were detected in 14-3-3?-depleted 3T3-L1 cells. Taken together, these data suggest that 14-3-3? is necessary for lipolysis from 3T3-L1 adipocytes. To understand adipocyte-specific roles of 14-3-3?, tamoxifen (TMX)-inducible, adipocyte-specific 14-3-3? knockout (adi14-3-3?KO) mice were used. Four weeks after TMX exposure (5 days, 50 mg/kg), no effects on body weight were found. After an overnight fast, adi14-3-3?KO mice displayed impaired lipolysis following i.p CL-316,243 (1 mg/kg) injections. In contrast, transgenic over-expression of 14-3-3? did not affect lipolysis. Adi14-3-3?KO mice also displayed glucose intolerance following i.p. glucose (2 g/kg). Real-time PCR confirmed significant reductions in Atgl, Hsl, and Pparg mRNA levels in adi14-3-3?KO mice, suggesting impaired adipocyte function. Collectively, these results demonstrate essential functions of 14-3-3? in facilitating lipolysis and, potentially, adipocyte maturity. Future studies are aimed at understanding how 14-3-3? regulates other aspects of adipocyte function, including diet-induced expansion of fat mass. Disclosure A. Oppong: None. Y. Mugabo: None. G.E. Lim: None. Funding Canadian Institutes of Health Research
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
